Dose- and time-dependent bimodal effects of κ-opioid agonists on locomotor activity in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 1031-1042

  Kuzmin, Alexander ^a   Sandin, Johan ^a   Terenius, Lars ^a   Ögren, Sven Ove ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,4 DICHLOROPHENYL)ACETYL 2 (1 PYRROLIDINYL); 2 (3,4 DICHLOROPHENYL) N METHYL N 1 (3 ISOTHIOCYANATOPHENYL) 2 (PYRROLIDINYL)ETHYL ACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZAMIDE; BETA FUNALTREXAMINE; BINALTORPHIMINE; BREMAZOCINE; BRL 52537; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; NALOXONE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; HABITUATION; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ACETAMIDES; ANIMALS; BENZOMORPHANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOTHIOCYANATES; MALE; MICE; MORPHINE; MOTOR ACTIVITY; NALOXONE; NALTREXONE; RECEPTORS, OPIOID, KAPPA; TIME FACTORS;

EID: 0033713994     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Evidence for multiple 'kappa' binding sites by use of opioid peptides in the guinea-pig lumbosacral spinal cord
2. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay
3. 2-(3,4-Dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrro lidinyl)ethyl]acetamide: An opioid receptor affinity label that produces selective and long-lasting kappa antagonism in mice
4. Kappa opioid receptor multiplicity: Evidence for two U50488H-sensitive kappa1 subtypes and a novel kappa3 subtype
5. The relative significance of spinal and supraspinal actions in the antinociceptive effect of morphine in the dorsal horn: An evaluation of the microinjection technique
6. Opioids can evoke direct receptor mediated excitatory effects on sensory neurons
7. International union of pharmacology. XII. Classification of opioid receptors
8. Sites of dopamine release inhibition by kappa agonists: Lack of local effect in the nucleus accumbens
9. Paradoxical effects of kappa-opioid stimulation on the locomotor activity and Fos immunoreactivity of the preweanling rat: Role of dopamine receptors
10. Increased responsiveness of mesolimbic and mesodtriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist
11. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadozacine: Further functional evidence of opioid receptor multiplicity in the mouse
12. Extremely long-lasting anatagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test
13. Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism
14. Observational analysis of the effects of kappa opioid agonists an open field behaviour in the rat
15. Long term kappa-opioid receptor blockade following nor-binaltorphimine
16. Potentiation of transmitter release from NMB human neuroblastoma cells by kappa-opioids is mediated by N-type voltage-dependent calcium channels
17. Properties of a selective kappa agonist U50488H
18. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications
19. Pharmacology of oploids
20. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists
21. Affinity of drugs and peptides for U69,593-sensitive and insensitive kappa-opioid binding sites: The U-69,593-insensitive site appears to be the beta-endorphin-specific epsilon receptor
22. Behavioral effects of ergot drugs
23. Substituted amphetamine derivatives. II. Behavioral effects in mice related to monoaminergic neurones
24. mu-Opposing actions of the kappa-opioid receptor
25. Review: Amino acid domains involved in constitutive activation of G-protein-coupled receptors
26. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes
27. Effects of U50488H on locomotor activity in the hamster
28. Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by G(s)-linked opioid receptors
29. The stimulatory effects of opioids and their possible role in the development of tolerance
30. Modulation of drug-induced sensitization processes by endogenous opioid systems
31. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse
32. (2S)-1-(arylacetyl)-2-(aminomethyl)piporidine derivatives: Novel, highly selective kappa opioid analgesics
33. The striatenigral dynorphin pathway of the rat studied with in vivo microdialysis. 1. Effects of K+ depolarization, lesions and peptidase inhibition